Crown BioScience experts explore organoid models and high-content imaging to evaluate T-cell-targeted therapies and ...

The following is a summary of “Cytokeratin 17 activates AKT signaling to induce epithelial-mesenchymal transition and promote bladder cancer progression,” published in the April 2025 issue of BMC ...

The following is a summary of "Epigenetic-modification associated hnRNPA3 acts as a prognostic biomarker and promotes malignant progression of HCC," published in the April 2025 issue of BMC Cancer by ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

Researchers have developed novel lymph-node-inspired hydrogels that significantly enhance the activation, gene expression, ...

Cancer drugs that inhibit CDK7 rapidly shut down pathways responsible for cell proliferation within minutes. For organs to ...

Researchers used integrated Mendelian randomization in a cohort of over 247,000 individuals to identify 62 plasma proteins associated with breast cancer risk. Nine high-confidence targets, including ...

Signet cell cancer is a rare type of cancer that mostly starts in the glandular cells. It is also called signet ring cell cancer. Nearly 57 out of 100 (57%) of all signet cell cancers start in the ...

The results challenge long-standing assumptions about the process called 'T-cell priming'. These new insights have significant ... Apr. 14, 2025 — Most cancer genome studies have focused on ...

Nanoplastics can enter the brain, accumulate in organs, and trigger inflammation. Learn how these invisible pollutants impact ...